140 related articles for article (PubMed ID: 25647473)
21. The antitumor agent doxorubicin binds to Fanconi anemia group F protein.
Kusayanagi T; Tsukuda S; Shimura S; Manita D; Iwakiri K; Kamisuki S; Takakusagi Y; Takeuchi T; Kuramochi K; Nakazaki A; Sakaguchi K; Kobayashi S; Sugawara F
Bioorg Med Chem; 2012 Nov; 20(21):6248-55. PubMed ID: 23026082
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
Wang Z; Li M; Lu S; Zhang Y; Wang H
Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
[TBL] [Abstract][Full Text] [Related]
23. Functional screen of the fanconi anemia pathway in cancer cells by Fancd2 immunoblot.
Van Der Heijden MS; Brody JR; Kern SE
Cancer Biol Ther; 2004 Jun; 3(6):534-7. PubMed ID: 15107617
[TBL] [Abstract][Full Text] [Related]
24. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
Peremartí J; Ramos F; Marcos R; Hernández A
Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
[TBL] [Abstract][Full Text] [Related]
25. Structure of the FA core ubiquitin ligase closing the ID clamp on DNA.
Wang S; Wang R; Peralta C; Yaseen A; Pavletich NP
Nat Struct Mol Biol; 2021 Mar; 28(3):300-309. PubMed ID: 33686268
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
27. Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining.
Houghtaling S; Newell A; Akkari Y; Taniguchi T; Olson S; Grompe M
Hum Mol Genet; 2005 Oct; 14(20):3027-33. PubMed ID: 16135554
[TBL] [Abstract][Full Text] [Related]
28. Caffeine Has a Synergistic Anticancer Effect with Cisplatin via Inhibiting Fanconi Anemia Group D2 Protein Monoubiquitination in Hepatocellular Carcinoma Cells.
Oda Y; Hidaka M; Suzuki A
Biol Pharm Bull; 2017 Nov; 40(11):2005-2009. PubMed ID: 28855448
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Fanconi anemia protein FANCD2 monoubiquitination by miR-302.
Suresh B; Kumar AM; Jeong HS; Cho YH; Ramakrishna S; Kim KS
Biochem Biophys Res Commun; 2015 Oct; 466(2):180-5. PubMed ID: 26343459
[TBL] [Abstract][Full Text] [Related]
30. Fancf-deficient mice are prone to develop ovarian tumours.
Bakker ST; van de Vrugt HJ; Visser JA; Delzenne-Goette E; van der Wal A; Berns MA; van de Ven M; Oostra AB; de Vries S; Kramer P; Arwert F; van der Valk M; de Winter JP; te Riele H
J Pathol; 2012 Jan; 226(1):28-39. PubMed ID: 21915857
[TBL] [Abstract][Full Text] [Related]
31. The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells.
Zhao L; Li Y; He M; Song Z; Lin S; Yu Z; Bai X; Wang E; Wei M
Int J Oncol; 2014 Jul; 45(1):129-38. PubMed ID: 24789349
[TBL] [Abstract][Full Text] [Related]
32. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.
Jacquemont C; Simon JA; D'Andrea AD; Taniguchi T
Mol Cancer; 2012 Apr; 11():26. PubMed ID: 22537224
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia.
Behera CK; Gyandeep G; Mishra R; Mohanty RP; Pal A; Behera J; Samal S; Das B
Mol Biol Rep; 2023 Jan; 50(1):931-936. PubMed ID: 36369330
[TBL] [Abstract][Full Text] [Related]
34. Replication stress induces accumulation of FANCD2 at central region of large fragile genes.
Okamoto Y; Iwasaki WM; Kugou K; Takahashi KK; Oda A; Sato K; Kobayashi W; Kawai H; Sakasai R; Takaori-Kondo A; Yamamoto T; Kanemaki MT; Taoka M; Isobe T; Kurumizaka H; Innan H; Ohta K; Ishiai M; Takata M
Nucleic Acids Res; 2018 Apr; 46(6):2932-2944. PubMed ID: 29394375
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma.
Yarde DN; Oliveira V; Mathews L; Wang X; Villagra A; Boulware D; Shain KH; Hazlehurst LA; Alsina M; Chen DT; Beg AA; Dalton WS
Cancer Res; 2009 Dec; 69(24):9367-75. PubMed ID: 19934314
[TBL] [Abstract][Full Text] [Related]
36. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
[TBL] [Abstract][Full Text] [Related]
38. FANCD2 and DNA Damage.
Nepal M; Che R; Ma C; Zhang J; Fei P
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825622
[TBL] [Abstract][Full Text] [Related]
39. The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells.
Chen Q; Van der Sluis PC; Boulware D; Hazlehurst LA; Dalton WS
Blood; 2005 Jul; 106(2):698-705. PubMed ID: 15802532
[TBL] [Abstract][Full Text] [Related]
40. A hidden role of the inactivated FANCD2: upregulating ΔNp63.
Panneerselvam J; Pickering A; Zhang J; Wang H; Tian H; Zheng J; Fei P
Oncotarget; 2013 Sep; 4(9):1416-26. PubMed ID: 23965832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
